Desjardins Global Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-831
Closed -$96.1K 704
2023
Q3
$96.1K Buy
+831
New +$96.1K 0.01% 479
2023
Q2
Sell
-2,124
Closed -$232K 656
2023
Q1
$232K Sell
2,124
-489
-19% -$53.4K 0.03% 388
2022
Q4
$297K Buy
2,613
+185
+8% +$21K 0.05% 298
2022
Q3
$150K Hold
2,428
0.02% 367
2022
Q2
$193K Buy
+2,428
New +$193K 0.03% 350